Media Outlet Bypasses Judge, Appeals DEA Chief for Cannabis Hearing Access
Cannabis news organization escalates push for public access to federal rescheduling proceedings after administrative law judge denies livestreaming request.
A cannabis industry publication has taken its request for livestreamed access to federal rescheduling hearings directly to DEA Administrator Anne Milgram after an administrative law judge rejected the petition for public broadcast of the proceedings. The move highlights growing pressure for transparency in what could become the most consequential cannabis policy decision in decades.
The rejection of public livestreaming access raises questions about transparency in proceedings that will directly impact billions in cannabis market capitalization. Major multi-state operators like Curaleaf Holdings (CURLF), Green Thumb Industries (GTBIF), and Trulieve Cannabis (TCNNF) have seen volatile trading patterns as investors await clarity on federal rescheduling timelines and implementation details.
The DEA's rescheduling review process continues to create uncertainty for cannabis investors, with limited public access to hearings that could determine whether cannabis moves from Schedule I to Schedule III under the Controlled Substances Act. This reclassification would eliminate the 280E tax burden that currently prevents cannabis companies from deducting standard business expenses, potentially adding hundreds of millions in annual cash flow across the sector.
Industry analysts view the transparency battle as indicative of broader regulatory challenges facing cannabis companies as they navigate federal policy changes. The lack of public access to these critical hearings compounds existing information gaps that have contributed to the sector's persistent valuation discount compared to other consumer goods industries.
The outcome of both the rescheduling decision and public access questions will likely influence investor confidence in cannabis stocks through 2024. With the industry already facing headwinds from oversupply in key markets and compressed margins, regulatory uncertainty continues to weigh on sector performance, making transparency in federal proceedings increasingly important for market participants seeking to assess policy risk and timing.